NCT03066921View on ClinicalTrials.gov

Evaluation Of The Efficacy of a Strain-Specific Probiotic Formulation in Hemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

December 31, 2017

Conditions
End Stage Renal Disease
Interventions
DIETARY_SUPPLEMENT

Probiotic packet

Probiotic formulation will be given at a dose of one packet thrice daily for 24 weeks, amounting to a total of 300 billion colony forming units(CFU)/day. Each packet contains 100 billion viable lyophilized bacteria of three strains of Lactobacillus viz Lactococcus lactis subsp. Lactis LL358 (BCRC910699)、Lactobacillus salivarius LS159 (BCRC910700) and Lactobacillus pentosus and excipients.

DIETARY_SUPPLEMENT

Placebo

Placebo packet will be given at a dose of one sachet thrice daily for 24 weeks; Placebo packet contain all excipients as present in packets (without the 3 strains of bacteria as mentioned above).

Trial Locations (1)

Unknown

Tungs' Taichung MetroHarbour Hospital, Taichung

All Listed Sponsors
lead

Paik Seong Lim

OTHER

NCT03066921 - Evaluation Of The Efficacy of a Strain-Specific Probiotic Formulation in Hemodialysis Patients | Biotech Hunter | Biotech Hunter